AtriCure, Inc. — Form 10-Q
Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 2/100
What the filing says
Michael H. Carrel (CEO) and Angela L. Wirick (CFO) have certified AtriCure's Form 10-Q for the quarter ended September 30, 2026, filed November 4, 2026. Both officers certify that financial statements fairly present the company's financial condition and results of operations, and that disclosure controls and internal controls over financial reporting are effective. No material weaknesses, deficiencies, or fraud are disclosed.
Why this rating
Standard Sarbanes-Oxley certifications; routine SEC filing requirement. No operational, financial, or strategic changes disclosed.
See more from November 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.